Medtech Insights

The Japanese IC device market is large but mature. Although there is modest procedural growth in PCI volumes and favorable reimbursement supporting the adoption of new technologies, strong MHLW…

The Latin America market for IC devices will expand moderately through 2027; although an expanding CAD patient pool and increasing adoption of premium-priced devices—such as next generation …

Demand for better patient outcomes will drive the uptake of novel technologies such as patient-conforming and 3-D printed implants, robotic- and navigation-assisted surgeries, and minimally…

The European varicose vein treatment device market remains underpenetrated and will see growth driven by the increasing adoption of minimally invasive procedures; the endovenous ablation market is…

The Latin America market for IC devices will expand moderately through 2027; although an expanding CAD patient pool and increasing adoption of premium-priced devices—such as next generation …

The growing market for digital breast tomosynthesis systems, along with rising demand for secondary diagnostic modalities such as dedicated breast MRI and BSGI as adjuncts for mammography…

An increasingly cost-conscious US health care landscape has placed substantial downward pressure on the large, yet contracting US IC device market. However, continuing innovation, alongside…

Demand for better patient outcomes will drive the uptake of premium innovations such as 3-D printed implants, nonfusion technologies, biologics, and minimally invasive devices. Furthermore, the…

Although the poor economic conditions in Latin America continue to create downward pricing pressures and hinder the adoption of premium-priced products such as advanced energy devices, the Latin…

he European varicose vein treatment device market will be characterized by shift toward and a changing reimbursement landscape for endovenous ablation technologies, namely ERFA and ELA, which…

The Asia Pacific vascular access device market will grow moderately through 2027, driven by an expanding patient population and increasing adoption of premium-priced devices. This Medtech 360…

The global therapeutic BTX market will grow strongly through 2027, with newly approved indications, the need for repeat BTX treatments, and a largely favorable reimbursement environment driving…